| Bioactivity | JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-3 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147952A1, compound 009)[1] |
| Name | JAK3/BTK-IN-3 |
| CAS | 2674036-98-5 |
| Formula | C22H28N8O |
| Molar Mass | 420.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Guobao Zhang, et al. Pyrimidopyrroles. Patent WO2021147952A1. |
JAK3/BTK-IN-3
CAS: 2674036-98-5 F: C22H28N8O W: 420.51
JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simulta
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.